Your browser doesn't support javascript.
loading
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs).
Sinatra, Laura; Bandolik, Jan J; Roatsch, Martin; Sönnichsen, Melf; Schoeder, Clara T; Hamacher, Alexandra; Schöler, Andrea; Borkhardt, Arndt; Meiler, Jens; Bhatia, Sanil; Kassack, Matthias U; Hansen, Finn K.
Afiliação
  • Sinatra L; Institute for Drug Discovery, Medical Faculty, Leipzig University, Brüderstraße 34, 04103, Leipzig, Germany.
  • Bandolik JJ; Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universität Düsseldorf, 40225, Düsseldorf, Germany.
  • Roatsch M; Institute for Drug Discovery, Medical Faculty, Leipzig University, Brüderstraße 34, 04103, Leipzig, Germany.
  • Sönnichsen M; Center for Biopharmaceuticals, Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen, Denmark.
  • Schoeder CT; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
  • Hamacher A; Center for Structural Biology, Department of Chemistry, Vanderbilt University, Nashville, TN, 37221, USA.
  • Schöler A; Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universität Düsseldorf, 40225, Düsseldorf, Germany.
  • Borkhardt A; Institute for Drug Discovery, Medical Faculty, Leipzig University, Brüderstraße 34, 04103, Leipzig, Germany.
  • Meiler J; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
  • Bhatia S; Institute for Drug Discovery, Medical Faculty, Leipzig University, Brüderstraße 34, 04103, Leipzig, Germany.
  • Kassack MU; Center for Structural Biology, Department of Chemistry, Vanderbilt University, Nashville, TN, 37221, USA.
  • Hansen FK; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Angew Chem Int Ed Engl ; 59(50): 22494-22499, 2020 12 07.
Article em En | MEDLINE | ID: mdl-32780485
ABSTRACT
Inhibition of more than one cancer-related pathway by multi-target agents is an emerging approach in modern anticancer drug discovery. Here, based on the well-established synergy between histone deacetylase inhibitors (HDACi) and alkylating agents, we present the discovery of a series of alkylating HDACi using a pharmacophore-linking strategy. For the parallel synthesis of the target compounds, we developed an efficient solid-phase-supported protocol using hydroxamic acids immobilized on resins (HAIRs) as stable and versatile building blocks for the preparation of functionalized HDACi. The most promising compound, 3 n, was significantly more active in apoptosis induction, activation of caspase 3/7, and formation of DNA damage (γ-H2AX) than the sum of the activities of either active principle alone. Furthermore, to demonstrate the utility of our preloaded resins, the HAIR approach was successfully extended to the synthesis of a proof-of-concept proteolysis-targeting chimera (PROTAC), which efficiently degrades histone deacetylases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resinas Sintéticas / Inibidores de Histona Desacetilases / Histona Desacetilases / Ácidos Hidroxâmicos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resinas Sintéticas / Inibidores de Histona Desacetilases / Histona Desacetilases / Ácidos Hidroxâmicos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article